A Phase 1 Randomized Double-Blind Study to Evaluate the Safety and Tolerability of a Vaccine against E. coli in Healthy Adults

Go Back to All Clinical Trials

A Phase 1 Randomized Double-Blind Study to Evaluate the Safety and Tolerability of a Vaccine against E. coli in Healthy Adults

Brief description of study

This is a Phase 1, randomized, observer-blind study to evaluate the safety, and tolerability, of FimH modRNA and O25b conjugate (with or without adjuvant) vaccine against E coli in healthy adults.

Clinical Study Identifier: s25-00138

Principal Investigator: Andrew Banks Fleming.

Other Investigators: Robert James Ulrich, Robert Anwar Pitts, Lalitha Parameswaran, Ramin Herati, Angelica Cifuentes Kottkamp, Madeline Alexandra DiLorenzo.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies